Cargando…
Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients
BACKGROUND: Patients with early colorectal cancer (stages I–II) generally have a good prognosis, but a subgroup of 15–20% experiences relapse and eventually die of disease. Occult metastases have been suggested as a marker for increased risk of recurrence in patients with node-negative disease. Usin...
Autores principales: | Lind, Guro E., Guriby, Marianne, Ahlquist, Terje, Hussain, Israr, Jeanmougin, Marine, Søreide, Kjetil, Kørner, Hartwig, Lothe, Ragnhild A., Nordgård, Oddmund |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584052/ https://www.ncbi.nlm.nih.gov/pubmed/28878843 http://dx.doi.org/10.1186/s13148-017-0397-4 |
Ejemplares similares
-
The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer
por: Oltedal, Satu, et al.
Publicado: (2018) -
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
por: Lind, Guro E, et al.
Publicado: (2011) -
Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A
por: Berg, Marianne, et al.
Publicado: (2015) -
A robust internal control for high-precision DNA methylation analyses by droplet digital PCR
por: Pharo, Heidi D., et al.
Publicado: (2018) -
Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability
por: Flatin, Bjørnar T.B., et al.
Publicado: (2020)